Pre-Tax Profit Margin (Quarterly)

Pre-Tax Profit Margin: Earnings before taxes as a portion of total revenue. Calculated as: Pre-Tax Income / Total Revenues

Bora Pharmaceuticals Co., Ltd. - Sponsored ADR (BORAY) had Pre-Tax Profit Margin of 19.13% for the most recently reported fiscal quarter, ending 2025-12-31.

Quarterly Annual

Figures for fiscal quarter ending 2025-12-31

Income Statement Financials
Revenue	155.45M
Net Income	11.96M
Cost of Goods Sold	98.98M
Gross Profit	56.47M
Operating Expenses	138.21M
Operating Income	17.24M
Non-Operating Income/Expense	12.50M
Pre-Tax Income	29.73M
Normalized Pre-Tax Income	29.73M
Income after Taxes	17.16M
Income from Continuous Operations	17.16M
Consolidated Net Income/Loss	13.03M
Normalized Income after Taxes	17.16M
EBIT	17.24M
EBITDA	24.75M
Weighted-Average Shares Outstanding (Basic)	623.78M
Weighted-Average Shares Outstanding (Diluted)	678.68M
Earnings per Share (EPS) (Basic)	-0.00
Earnings per Share (EPS) (Diluted)	0.00
Balance Sheet Financials
Current Assets	620.74M
Property, Plant, and Equipment	334.91M
Long-Term Assets	814.59M
Total Assets	1.44B
Current Liabilities	427.60M
Long-Term Debt	378.66M
Long-Term Liabilities	446.87M
Total Liabilities	874.47M
Common Equity	560.86M
Tangible Shareholders Equity	360.41M
Shareholders Equity	560.86M
Common Shares Outstanding	634.94M
Cash Flow Statement Financials
Cash Flow from Operating Activities	144.57M
Cash Flow from Investing Activities	-108.49M
Cash Flow from Financial Activities	-44.20M
Beginning Cash	187.12M
End Cash	162.97M
Increase/Decrease in Cash	-24.15M
Stock-Based Compensation	2.52M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.45
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.40
Debt to Equity Ratio	1.00
Gross Margin	36.33%
Operating Margin	11.09%
EBIT Margin	11.09%
EBITDA Margin	--
Pre-Tax Profit Margin	19.13%
Profit Margin	7.69%
Free Cash Flow	123.30M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.11
Inventory Turnover	0.90
Receiveable Turnover	0.53
Days Sales in Receivables	169.77
Return on Equity	3.06%
Return on Tangible Equity	4.76%
Return on Assets	1.20%
Return on Investments	1.83%
Book Value Per Share	0.88
Free Cash Flow per Share	0.18
Operating Cash Flow per Share	0.21

Data from Zacks Investment Research, Inc.